MedPath

A prospective clinical trial with sequential cohorts on the effect of individualized prognostic counselling on treatment decisions and quality of life in patients with head and neck cancer.

Recruiting
Conditions
plaveiselcelcarcinoom van het hoofd-hals gebied
head and neck squamous cell carcinoma
10027655
Registration Number
NL-OMON47696
Lead Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
400
Inclusion Criteria

Primary squamous cell carcinoma of lip, nasopharynx, oral cavity, oropharynx, larynx or hypopharynx
Second primary squamous cell carcinoma of lip, nasopharynx, oral cavity, oropharynx, larynx or hypopharynx
Curative intent
Follow-up takes place in the Erasmus MC
Written informed consent from the patient

Exclusion Criteria

No curative intent based on tumor site and tumor characteristics
Recurrent tumor
Simultaneous or synchronic multiple primary HNSCC
Illiterate patient
Insufficient knowledge of Dutch language
Incompetent (due to a.o. mental state) to consider their own treatment choice

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>* A significant reduction of decisional conflict in the intervention group.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>* Fraction of patients who choose not to follow RWHHT advice and therefore<br /><br>receive a non-protocol based treatment in the intervention group.<br /><br>* Quality of life: level of quality of life, specified on head and neck cancer,<br /><br>anxiety and/or distress.<br /><br>* (Disease-free) survival rates: recurrence of the tumor, death and cause of<br /><br>death<br /><br>* Socio-economic status: highest level of education, current profession and<br /><br>postal code of the home address</p><br>
© Copyright 2025. All Rights Reserved by MedPath